1. Home
  2. OMCL vs ARDX Comparison

OMCL vs ARDX Comparison

Compare OMCL & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omnicell Inc. ($0.001 par value)

OMCL

Omnicell Inc. ($0.001 par value)

HOLD

Current Price

$34.96

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.65

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMCL
ARDX
Founded
1992
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
OMCL
ARDX
Price
$34.96
$5.65
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$53.67
$15.14
AVG Volume (30 Days)
517.9K
3.0M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$787,309,000.00
$2,607,000.00
Revenue This Year
$6.77
$37.75
Revenue Next Year
$5.22
$34.24
P/E Ratio
$857.75
N/A
Revenue Growth
9.93
N/A
52 Week Low
$22.66
$3.50
52 Week High
$51.84
$8.40

Technical Indicators

Market Signals
Indicator
OMCL
ARDX
Relative Strength Index (RSI) 37.86 40.44
Support Level $33.25 $5.49
Resistance Level $37.51 $6.63
Average True Range (ATR) 1.33 0.23
MACD -0.09 -0.02
Stochastic Oscillator 26.83 49.01

Price Performance

Historical Comparison
OMCL
ARDX

About OMCL Omnicell Inc. ($0.001 par value)

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: